PT75050B - Production of foot and mouth disease vaccine from microbially expressed antigens thereof - Google Patents

Production of foot and mouth disease vaccine from microbially expressed antigens thereof

Info

Publication number
PT75050B
PT75050B PT75050A PT7505082A PT75050B PT 75050 B PT75050 B PT 75050B PT 75050 A PT75050 A PT 75050A PT 7505082 A PT7505082 A PT 7505082A PT 75050 B PT75050 B PT 75050B
Authority
PT
Portugal
Prior art keywords
foot
production
mouth disease
disease vaccine
expressed antigens
Prior art date
Application number
PT75050A
Other languages
English (en)
Other versions
PT75050A (en
Inventor
Dennis G Kleid
Daniel G Yansura
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PT75050A publication Critical patent/PT75050A/pt
Publication of PT75050B publication Critical patent/PT75050B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT75050A 1981-06-16 1982-06-14 Production of foot and mouth disease vaccine from microbially expressed antigens thereof PT75050B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27410381A 1981-06-16 1981-06-16
US37485582A 1982-05-04 1982-05-04

Publications (2)

Publication Number Publication Date
PT75050A PT75050A (en) 1982-07-01
PT75050B true PT75050B (en) 1984-02-21

Family

ID=26956602

Family Applications (1)

Application Number Title Priority Date Filing Date
PT75050A PT75050B (en) 1981-06-16 1982-06-14 Production of foot and mouth disease vaccine from microbially expressed antigens thereof

Country Status (8)

Country Link
EP (1) EP0068693A3 (pt)
BR (1) BR8203507A (pt)
DK (1) DK268882A (pt)
ES (1) ES513159A0 (pt)
GB (1) GB2103622B (pt)
IE (1) IE53375B1 (pt)
PT (1) PT75050B (pt)
ZW (1) ZW11982A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2084583B (en) * 1980-09-18 1984-12-19 Nat Res Dev Synthetic dna and process therefor
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen
US5230888A (en) * 1982-05-06 1993-07-27 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
US4751083A (en) * 1982-05-06 1988-06-14 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
EP0105481A1 (en) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Novel antigens and vaccines containing them
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
US4769237A (en) * 1983-03-25 1988-09-06 Bittle James L Synthetic picornavirus antigen
NZ209308A (en) 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US5539092A (en) * 1992-10-02 1996-07-23 Arch Development Corporation Cyanobacterial and plant acetyl-CoA carboxylase
US6306636B1 (en) 1997-09-19 2001-10-23 Arch Development Corporation Nucleic acid segments encoding wheat acetyl-CoA carboxylase
KR20070100307A (ko) 2004-12-22 2007-10-10 제넨테크, 인크. 가용성 다중 막관통 단백질의 생산 방법
WO2009003037A1 (en) 2007-06-27 2008-12-31 The Board Of Trustees Of The Leland Stanford Junior University Peptide tyrosinase inhibitors and uses thereof
CN104792990A (zh) * 2015-03-31 2015-07-22 洛阳莱普生信息科技有限公司 一种a型口蹄疫竞争elisa抗体检测试剂盒
CN105399802B (zh) * 2015-12-08 2020-04-03 中国农业科学院兰州兽医研究所 A型口蹄疫基因工程复合表位蛋白及疫苗
CN105622762B (zh) * 2016-03-03 2020-04-03 中国农业科学院兰州兽医研究所 一种牛趋化因子介导的o型口蹄疫靶向性复合表位蛋白及疫苗
CN105777909B (zh) * 2016-03-03 2020-04-03 中国农业科学院兰州兽医研究所 一种猪趋化因子介导的a型口蹄疫靶向性复合表位蛋白及疫苗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8304204A1 (es) * 1980-05-12 1983-02-16 Biogen Nv Un metodo de producir un polipeptido que presenta la especialidad de los antigenos virales de la glosopeda (fmo).
DE3177298T2 (de) * 1980-06-06 1993-07-01 Biogen Inc Verbesserte vektoren, verfahren zur herstellung solcher vektoren und zur expression von klonierten genen.
GB2084583B (en) * 1980-09-18 1984-12-19 Nat Res Dev Synthetic dna and process therefor

Also Published As

Publication number Publication date
GB2103622B (en) 1986-01-15
PT75050A (en) 1982-07-01
EP0068693A2 (en) 1983-01-05
DK268882A (da) 1983-02-02
ES8400145A1 (es) 1983-11-01
IE821428L (en) 1982-12-16
GB2103622A (en) 1983-02-23
IE53375B1 (en) 1988-10-26
ZW11982A1 (en) 1982-11-10
EP0068693A3 (en) 1983-07-20
BR8203507A (pt) 1983-06-07
ES513159A0 (es) 1983-11-01

Similar Documents

Publication Publication Date Title
GB2103622B (en) Production of foot and mouth disease vaccine from microbially expressed antigens
GB8822749D0 (en) Vaccine containing tumour antigens & adjuvants
ZA831854B (en) Small peptides with the specificity of foot and mouth disease viral antigens
EP0130690A3 (en) Pharmaceutical preparation for remedy of periodontal disease and process for production thereof
NO172325C (no) Munnpreparat
NZ216362A (en) Synthetic vaccine for foot and mouth disease
FR2499414B1 (fr) Production d'anticorps proteiniques humains
GB2094157B (en) Infant's pacifier
FR2489151B1 (fr) Production d'hormone luteinisante humaine
ZA889718B (en) Continuous process for the preparation of gelatin from powered bone and gelatin obtained
ZA824174B (en) Production of foot and mouth disease vaccine from microbially expressed antigens thereof
JPS5585524A (en) Respiratory tract vaccine and its manufacture
AR243081A1 (es) Procedimiento para preparar una vacuna sintetica contra la fiebre aftosa.
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
IL66042A0 (en) Production of foot and mouth disease vaccine from microbially expressed antigens thereof
ZA828574B (en) Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it
EP0314316A3 (en) Preparation of modified polysiloxanes
ZW26082A1 (en) Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it
JPS5589232A (en) Vaccines against reo virus disease and their manufacture
JPS56100054A (en) Technique of dental medicine
JPS55122712A (en) Novel medicine state of oral drug and its manufacture
CS578887A1 (en) Inactivated antigen of cattle's mucosal disease's virus
PT74968A (fr) Procede pour la preparation d'une vaccin contre les brucelloses humaines
PH24366A (en) Synthetic vaccines for foot and mouth disease
JPS57129800A (en) Manufacture of ornament shaping animal